Loading...

IRTC - iRhythm Technologies, Inc.

Analyst Downgrade Signal for 06-09-2022
Analyst Downgrade Signal: IRTC from Buy to Neutral by Citigroup
Price Target: $180>>155


Loading Chart IRTC

Stock Signal Information


Signal

Analyst Downgrade Signal: IRTC from Buy to Neutral by Citigroup
Price Target: $180>>155
Report Date: 06-09-2022
Symbol: IRTC - iRhythm Technologies, Inc.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Analyst Downgrade Signal: IRTC from Buy to Neutral by Citigroup
Price Target: $180>>155

  IRTC Technical Analysis

Company Contact

iRhythm Technologies, Inc. (IRTC)
650 Townsend St Ste 500
San Francisco, CALIFORNIA 94103
Phone: 14156325700
Website: http://www.irhythmtech.com
CEO: Mr. Kevin King

IRTC, iRhythm Technologies, Inc.

IRTC iRhythm Technologies, Inc. Logo Image

NASDAQ, Nasdaq Global Select


Company Profile

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was founded in 2006 and is headquartered in San Francisco, California.